SCHEMBL30494290

SCHEMBL30494290

CN1C(=O)/C(=C/c2ccc3ncn(C)c3c2)N=C1NC1CCCCCC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DYRK2 Q92630 13/20 0.49
▸ DYRK1A Q13627 8/20 0.49
▸ DYRK1B Q9Y463 8/20 0.49
▸ CDK5 Q00535 7/20 0.49
▸ CDK5R1 Q15078 7/20 0.49
▸ CLK1 P49759 7/20 0.49
▸ CLK4 Q9HAZ1 6/20 0.49
▸ DYRK3 O43781 6/20 0.49
▸ CLK2 P49760 5/20 0.49
▸ DYRK4 Q9NR20 4/20 0.49
▸ CLK3 P49761 3/20 0.49
▸ GSK3B P49841 2/20 0.40
▸ PIM1 P11309 6/20 0.39
▸ CDK9 P50750 1/20 0.36
▸ FLT3 P36888 1/20 0.35
▸ GSK3A P49840 1/20 0.35
▸ LTB4R Q15722 1/20 0.35
▸ SYK P43405 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26093713 1.00 DYRK2 (0.49) DYRK2DYRK1ADYRK1BCDK5CDK5R1
SCHEMBL26093420 1.00 DYRK2 (0.49) DYRK2DYRK1ADYRK1BCDK5CDK5R1
SCHEMBL26096259 1.00 DYRK2 (0.49) DYRK2DYRK1ADYRK1BCDK5CDK5R1
SCHEMBL30494051 1.00 DYRK2 (0.49) DYRK2DYRK1ADYRK1BCDK5CDK5R1
SCHEMBL30494253 1.00 DYRK2 (0.49) DYRK2DYRK1ADYRK1BCDK5CDK5R1
SCHEMBL30494046 0.89 DYRK2 (0.41) DYRK2DYRK1ADYRK1BCDK5CDK5R1
SCHEMBL26095733 0.89 DYRK2 (0.41) DYRK2DYRK1ADYRK1BCDK5CDK5R1
SCHEMBL30363449 0.85 DYRK2 (0.42) DYRK2DYRK1ADYRK1BCDK5CDK5R1
SCHEMBL30363324 0.85 DYRK2 (0.42) DYRK2DYRK1ADYRK1BCDK5CDK5R1
SCHEMBL26106241 0.85 DYRK2 (0.42) DYRK2DYRK1ADYRK1BCDK5CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4422753-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 Perha Pharmaceuticals (FR) 2024-09-04 — — EP claimed
WO-2023072966-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 PERHA PHARMACEUTICALS (FR) 2023-05-04 — — WO claimed
EP-4422753-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 Perha Pharmaceuticals (FR) 2024-09-04 — — EP disclosed
WO-2023072966-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 PERHA PHARMACEUTICALS (FR) 2023-05-04 — — WO disclosed
Send feedback